The host response to endotoxin-contaminated dermal matrix

Tissue Engineering - Part A

Volumn 18, Issue 11-12, 2012, Pages 1293-1303

  Daly, Kerry A ^a   Liu, Sandy ^b   Agrawal, Vineet ^a,c   Brown, Bryan N ^a   Huber, Alexander ^a   Johnson, Scott A ^a   Reing, Janet ^a   Sicari, Brian ^a   Wolf, Matthew ^a,b   Zhang, Xiaoran ^c   Badylak, Stephen F ^a,b  

^a MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTAMINATION; IMMUNOLOGY; TISSUE;

ADVERSE EFFECT; CLINICAL STUDY; DELETERIOUS EFFECTS; DERMAL MATRIX; EXTRACELLULAR MATRICES; FOOD AND DRUG ADMINISTRATION; HOST IMMUNE RESPONSE; HOST RESPONSE; HOST TISSUES; IMMUNE RESPONSE; IN-VITRO; POST-IMPLANTATION; PROINFLAMMATORY RESPONSE; SCAFFOLD MATERIALS; SITE-SPECIFIC; TISSUE REMODELING;

SCAFFOLDS (BIOLOGY);

SUS;

ENDOTOXIN; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BODY TEMPERATURE; CELL COUNT; CELL DEATH; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DERMIS; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMPLANT; IMPLANTATION; METABOLISM; MONOCYTE; RAT; SECRETION; SPRAGUE DAWLEY RAT; STAINING; SWINE;

ANIMALS; BODY TEMPERATURE; CELL COUNT; CELL DEATH; CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL2; CHEMOKINE CCL4; DERMIS; ENDOTOXINS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMPLANTS, EXPERIMENTAL; INTERLEUKIN-10; MONOCYTES; PROSTHESIS IMPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STAINING AND LABELING; SUS SCROFA; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861837064     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0597     Document Type: Review

References (38)

1. Daly, K.A., Stewart-Akers, A.M., Hara, H., Ezzelarab, M., Long, C., Cordero, K., et al. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 15, 3877, 2009.
2. Valentin, J.E., Badylak, J.S., McCabe, G.P., and Badylak, S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 88, 2673, 2006.
3. Turner, N.J., Yates, A.J., Jr., Weber, D.J., Qureshi, I.R., Stolz, D.B., Gilbert, T.W., et al. Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. Tissue Eng Part A 16, 3309, 2010.
4. Brown, B.N., Valentin, J.E., Stewart-Akers, A.M., McCabe, G.P., and Badylak, S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482, 2009.
5. Nuininga, J.E., van Moerkerk, H., Hanssen, A., Hulsbergen, C.A., Oosterwijk-Wakka, J., Oosterwijk, E., et al. A rabbit model to tissue engineer the bladder. Biomaterials 25, 1657, 2004.
6. Reddy, P.P., Barrieras, D.J., Wilson, G., Bagli, D.J., McLorie, G.A., Khoury, A.E., et al. Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 164, 936, 2000.
7. Quarti, A., Nardone, S., Colaneri, M., Santoro, G., and Pozzi, M. Preliminary experience in the use of an extracellular matrix to repair congenital heart disases. Interact Cardiovasc Thorac Surg 13, 569, 2012.
8. Badylak, S.F., Kochupura, P.V., Cohen, I.S., Doronin, S.V., Saltman, A.E., Gilbert, T.W., et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 15 Suppl 1, S29, 2006.
9. Schaner, P.J., Martin, N.D., Tulenko, T.N., Shapiro, I.M., Tarola, N.A., Leichter, R.F., et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 40, 146, 2004.
10. Badylak, S.F., Vorp, D.A., Spievack, A.R., Simmons-Byrd, A., Hanke, J., Freytes, D.O., et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 128, 87, 2005.
11. Urita, Y., Komuro, H., Chen, G., Shinya, M., Kaneko, S., Kaneko, M., et al. Regeneration of the esophagus using gastric acellular matrix: an experimental study in a rat model. Pediatr Surg Int 23, 21, 2007.
12. Clough, A., Ball, J., Smith, G.S., and Leibman, S. Porcine small intestine submucosa matrix (Surgisis) for esophageal perforation. Ann Thorac Surg 91, e15, 2011.
13. Franklin, M.E., Jr., Trevino, J.M., Portillo, G., Vela, I., Glass, J.L., and Gonzalez, J.J. The use of porcine small intestinal submucosa as a prosthetic material for laparoscopic hernia repair in infected and potentially contaminated fields: longterm follow-up. Surg Endosc 22, 1941, 2008.
14. Mase, V.J., Jr., Hsu, J.R., Wolf, S.E., Wenke, J.C., Baer, D.G., Owens, J., et al. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 33, 511, 2010.
15. Badylak, S.F., Hoppo, T., Nieponice, A., Gilbert, T.W., Davison, J.M., and Jobe, B.A. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 17, 1643, 2011.
16. Allman, A.J., McPherson, T.B., Badylak, S.F., Merrill, L.C., Kallakury, B., Sheehan, C., et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 71, 1631, 2001.
17. Valentin, J.E., Stewart-Akers, A.M., Gilbert, T.W., and Badylak, S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15, 1687, 2009.
18. Badylak, S.F., and Gilbert, T.W. Immune response to biologic scaffold materials. Semin Immunol 20, 109, 2008.
19. Ansaloni, L., Cambrini, P., Catena, F., Di Saverio, S., Gagliardi, S., Gazzotti, F., et al. Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations. J Invest Surg 20, 237, 2007.
20. van Putten, S.M., Wubben, M., Plantinga, J.A., Hennink, W.E., van Luyn, M.J., and Harmsen, M.C. Endotoxin contamination delays the foreign body reaction. J Biomed Mater Res A 98, 527, 2011.
21. Brightbill, H.D., Libraty, D.H., Krutzik, S.R., Yang, R.B., Belisle, J.T., Bleharski, J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732, 1999.
22. U.S. Food and Drug Administration. Guideline on the Validation of the Limulus Amebocyte Lysate Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices. Silver Spring, MD, 1987.
23. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25, 402, 2001.
24. Biswas, S.K., and Sodhi, A. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. J Interferon Cytokine Res 22, 527, 2002.
25. Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H., Ishiwata, Y., Asano, M., et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165, 237, 2004.
26. Chow, F.Y., Nikolic-Paterson, D.J., Ma, F.Y., Ozols, E., Rollins, B.J., and Tesch, G.H. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50, 471, 2007.
27. Daly, K.A., Liu, S., Agrawal, V., Brown, B.N., Johnson, S.A., Medberry, C.J., et al. Damage associated molecular patterns within xenogenic biologic scaffolds and their potential effects on host remodeling. Biomaterials 33, 91, 2012.
28. Chen, H., Li, P., Yin, Y., Cai, X., Huang, Z., Chen, J., et al. The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. Biomaterials 31, 8172, 2010.
29. Shokouhi, B., Coban, C., Hasirci, V., Aydin, E., Dhanasingh, A., Shi, N., et al. The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials 31, 5759, 2010.
30. Rogers, T.H., and Babensee, J.E. Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice. Biomaterials 31, 594, 2010.
31. Sharp, P.E., La Regina, M.C., and Suckow, M.A. The Laboratory Rat. Boca Raton, FL: CRC Press, 1998.
32. Seki, E., De Minicis, S., Osterreicher, C.H., Kluwe, J., Osawa, Y., Brenner, D.A., et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13, 1324, 2007.
33. Seki, E., Tsutsui, H., Iimuro, Y., Naka, T., Son, G., Akira, S., et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41, 443, 2005.
34. Wang, S., Schmaderer, C., Kiss, E., Schmidt, C., Bonrouhi, M., Porubsky, S., et al. Recipient toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIFdependent signaling. Dis Model Mech 3, 92, 2010.
35. Mendes, M.E., Baggio-Zappia, G.L., Brunialti, M.K., Fernandes Mda, L., Rapozo, M.M., and Salomao, R. Differential expression of toll-like receptor signaling cascades in LPStolerant human peripheral blood mononuclear cells. Immunobiology 216, 285, 2011.
36. Santos, T.C., Marques, A.P., Horing, B., Martins, A.R., Tuzlakoglu, K., Castro, A.G., et al. In vivo short-term and longterm host reaction to starch-based scaffolds. Acta Biomater 6, 4314, 2010.
37. Schutte, R.J., Xie, L., Klitzman, B., and Reichert, W.M. In vivo cytokine-associated responses to biomaterials. Biomaterials 30, 160, 2009.
38. Schutte, R.J., Parisi-Amon, A., and Reichert, W.M. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 88, 128, 2009.